SABA, Vittorio
 Distribuzione geografica
Continente #
NA - Nord America 5.186
EU - Europa 2.859
AS - Asia 2.331
SA - Sud America 527
AF - Africa 128
Continente sconosciuto - Info sul continente non disponibili 97
OC - Oceania 5
Totale 11.133
Nazione #
US - Stati Uniti d'America 5.030
RU - Federazione Russa 1.028
SG - Singapore 892
VN - Vietnam 427
UA - Ucraina 397
BR - Brasile 392
CN - Cina 349
SE - Svezia 239
IT - Italia 225
DE - Germania 204
TR - Turchia 203
IE - Irlanda 199
HK - Hong Kong 170
DK - Danimarca 151
FR - Francia 141
FI - Finlandia 116
KR - Corea 81
GB - Regno Unito 74
CI - Costa d'Avorio 61
CA - Canada 56
MX - Messico 48
AR - Argentina 47
BD - Bangladesh 39
IN - India 34
CO - Colombia 23
IQ - Iraq 23
EC - Ecuador 22
ZA - Sudafrica 22
PL - Polonia 20
ID - Indonesia 18
JP - Giappone 18
MA - Marocco 18
NL - Olanda 12
PK - Pakistan 12
CL - Cile 11
CR - Costa Rica 10
PY - Paraguay 9
VE - Venezuela 9
HN - Honduras 8
UZ - Uzbekistan 8
BE - Belgio 7
ES - Italia 7
RO - Romania 7
TN - Tunisia 7
TT - Trinidad e Tobago 7
AT - Austria 6
MY - Malesia 6
OM - Oman 6
PH - Filippine 6
SV - El Salvador 6
UY - Uruguay 6
EG - Egitto 5
JO - Giordania 5
LT - Lituania 5
PR - Porto Rico 5
SA - Arabia Saudita 5
AL - Albania 4
BG - Bulgaria 4
CW - ???statistics.table.value.countryCode.CW??? 4
DZ - Algeria 4
GT - Guatemala 4
IL - Israele 4
KE - Kenya 4
PE - Perù 4
AE - Emirati Arabi Uniti 3
AU - Australia 3
DO - Repubblica Dominicana 3
EE - Estonia 3
IR - Iran 3
KZ - Kazakistan 3
NI - Nicaragua 3
NP - Nepal 3
AZ - Azerbaigian 2
BO - Bolivia 2
CY - Cipro 2
EU - Europa 2
KG - Kirghizistan 2
MD - Moldavia 2
PA - Panama 2
PS - Palestinian Territory 2
AO - Angola 1
BB - Barbados 1
BH - Bahrain 1
BJ - Benin 1
BY - Bielorussia 1
CG - Congo 1
CV - Capo Verde 1
CZ - Repubblica Ceca 1
DM - Dominica 1
ET - Etiopia 1
GP - Guadalupe 1
GY - Guiana 1
HU - Ungheria 1
IS - Islanda 1
JM - Giamaica 1
KH - Cambogia 1
KW - Kuwait 1
LB - Libano 1
LU - Lussemburgo 1
LV - Lettonia 1
Totale 11.034
Città #
Ashburn 907
Singapore 548
Jacksonville 396
Chandler 350
Dallas 271
San Jose 265
Fairfield 251
Dublin 199
Council Bluffs 184
Boardman 183
Hong Kong 163
Ho Chi Minh City 145
Wilmington 143
New York 130
Woodbridge 120
Hanoi 114
Seattle 112
Moscow 110
Houston 108
Beijing 100
Princeton 87
Lawrence 79
San Mateo 79
Lauterbourg 70
Ann Arbor 69
Cambridge 69
Los Angeles 63
Abidjan 61
The Dalles 59
Hefei 57
São Paulo 47
Turin 45
Buffalo 44
Phoenix 40
Orem 31
Munich 29
Santa Clara 28
Da Nang 23
Des Moines 21
Milan 21
Chelsea 20
Mexico City 20
San Diego 20
Turku 19
Warsaw 19
Helsinki 18
London 18
Denver 17
Montreal 17
Chicago 15
Haiphong 15
Tokyo 15
Atlanta 13
Johannesburg 13
Shanghai 13
Chennai 12
Miano 12
Brooklyn 11
Biên Hòa 10
Brasília 10
Izmir 10
Stockholm 10
Wuhan 10
Columbus 9
Guayaquil 9
Manchester 9
Rio de Janeiro 9
Buenos Aires 8
Can Tho 8
Guangzhou 8
Nuremberg 8
Poplar 8
Rome 8
Tashkent 8
Baghdad 7
Bogotá 7
Campinas 7
Falls Church 7
Jakarta 7
Washington 7
Wembley 7
Belo Horizonte 6
Brussels 6
Dhaka 6
Montevideo 6
Mumbai 6
Norwalk 6
Querétaro 6
San José 6
Amsterdam 5
Aracaju 5
Caracas 5
Charlotte 5
Curitiba 5
Detroit 5
Kazan' 5
Kilburn 5
Maceió 5
Muscat 5
Naples 5
Totale 6.402
Nome #
1267 HSP70-2 polymorphism as a risk factor for carotid plaque rupture and cerebral ischaemia in old type 2 diabetes-atherosclerotic patients 784
Prophylactic efficacy of topical temporin A and RNAIII-inhibiting peptide in a subcutaneous rat pouch model of graft infection attributable to staphylococci with intermediate resistance to glycopeptides 275
RNAIII-inhibiting peptide in combination with the cathelicidin BMAP-28 reduces lethality in mouse models of staphylococcal sepsis 239
Citropin 1.1-treated central venous catheters improve the efficacy of hydrophobic antibiotics in the treatment of experimental staphylococcal catheter-related infection. 215
BisEDT and RIP act in synergy to prevent graft infections by resistant staphylococci. 208
Administration of protegrin peptide IB-367 to prevent endotoxin induced mortality in bile duct ligated rats. 191
Cecropin B enhances betalactams activities in experimental rat models of gram-negative septic shock 170
Attività ed espressione della ossido-nitrico sintetasi nella vescica di ratti sottoposti a neuromodulazione sacrale 169
Cathelicidin peptide sheep myeloid antimicrobial peptide-29 prevents endotoxin-induced mortality in rat models of septic shock 163
Antiendotoxin activity of antimicrobial peptides and glycopeptides. 161
Comparative efficacies of quinupristin-dalfopristin, linezolid, vancomycin, and ciprofloxacin in treatment, using the antibiotic-lock technique, of experimental catheter-related infection due to Staphylococcus aureus. 157
Amphibian Peptides Prevent Endotoxemia and Bacterial Translocation in Bile Duct-Ligated Rats 156
Therapeutic efficacy of intraperitoneal polymyxin B and polymyxin-like peptides alone or combined with levofloxacin in rat models of septic shock 155
Antiendotoxin activity of protegrin analog IB-367 alone or in combination with piperacillin in different animal models of septic shock 151
The antimicrobial peptide BMAP-28 reduces lethality in mouse models of staphylococcal sepsis 150
A chimeric peptide composed of a dermaseptin derivative and an RNA III-inhibiting peptide prevents graft-associated infections by antibiotic-resistant staphylococci. 148
Antiseptic compounds still active against bacterial strains isolated from surgical wound infections despite increasing antibiotic resistance. 147
Activity and expression of nitric oxide synthase in rat bladder after sacral neuromodulation 144
Efficacy of tachyplesin III, colistin, and imipenem against a multiresistant Pseudomonas aeruginosa strain. 141
Therapeutic efficacy of the magainin analogue MSI-78 in different intra-abdominal sepsis rat models. 141
Interaction of antimicrobial peptide temporin L with lipopolysaccharide in vitro and in experimental rat models of septic shock caused by gram-negative bacteria. 140
Mupirocin prophylaxis against methicillin-susceptible, methicillin-resistant, or vancomycin-intermediate Staphylococcus epidermidis vascular-graft infection. 138
[Vascular graft infection by Staphylococcus epidermidis: efficacy of various perioperative prophylaxis protocols in an animal model]. 138
Distinctin improves the efficacies of glycopeptides and betalactams against staphylococcal biofilm in an experimental model of central venous catheter infection. 138
Cationic peptides combined with betalactams reduce mortality from peritonitis in experimental rat model. 135
RNAIII-Inhibiting Peptide-Loaded Polymethylmethacrylate Prevents In Vivo Staphylococcus aureus Biofilm Formation 134
RNAIII-inhibiting peptide significantly reduces bacterial load and enhances the effect of antibiotics in the treatment of central venous catheter-associated Staphylococcus aureus infections. 134
Pre-treatment of central venous catheters with the cathelicidin BMAP-28 enhances the efficacy of antistaphylococcal agents in the treatment of experimental catheter-related infection. 132
Effects of pexiganan alone and combined with betalactams in experimental endotoxic shock 132
Single-dose intraperitoneal magainins improve survival in a gram-negative-pathogen septic shock rat model. 131
Experimental study on the efficacy of combination of alpha-helical antimicrobial peptides and vancomycin against Staphylococcus aureus with intermediate resistance to glycopeptides. 130
Temporin A soaking in combination with intraperitoneal linezolid prevents vascular graft infection in a subcutaneous rat pouch model of infection with Staphylococcus epidermidis with intermediate resistance to glycopeptides. 130
Suppression of drug-resistant Staphylococcal Infections by the quorum-sensing inhibitor RNAIII-inhibiting peptide. 129
LL-37 protects rats against lethal gram-negative sepsis. 127
Temporin A alone and in combination with imipenem reduces lethality in a mouse model of staphylococcal sepsis. 127
Comparative efficacy of quinupristin/dalfopristin, linezolid, vancomycin and ciprofloxacin in the treatment of experimental catheter-related infection due to Staphylococcus aureus using the antibiotic-lock technique 126
LL-37 protects rats against lethal sepsis caused by gram-negative bacteria. 126
Protective effects of the combination of alpha-helical antimicrobial peptides and rifampicin in three rat models of Pseudomonas aeruginosa infection. 125
RNA III inhibiting peptide inhibits in vivo biofilm formation by drug-resistant Staphylococcus aureus. 124
Efficacy of colistin/rifampin combination in experimental rat models of sepsis due to a multiresistant Pseudomonas aeruginosa strain. 123
Efficacy of quinupristin/dalfopristin in preventing vascular graft infection due to Staphylococcus epidermidis with intermediate resistance to glycopeptides. 123
Neutralization of endotoxin in vitro and in vivo by Bac7(1-35), a proline-rich antibacterial peptide 122
Effects of the antimicrobial peptide BMAP-27 in a mouse model of obstructive jaundice stimulated by lipopolysaccharide 122
Prophylaxis against Staphylococcus aureus vascular graft infection with mupirocin-soaked, collagen-sealed dacron. 122
Temporin A is effective in MRSA-infected wounds through bactericidal activity and acceleration of wound repair in a murine model. 121
Prophylactic efficacy of linezolid alone or combined with levofloxacin and vancomycin in a rat subcutaneous pouch model of graft infection caused by Staphylococcus epidermidis with intermediate resistance to glycopeptides. 120
Use of the quorum-sensing inhibitor RNAIII-inhibiting peptide to prevent biofilm formation in vivo by drug-resistant Staphylococcus epidermidis. 120
Temporin A as a prophylactic agent against methicillin sodium-susceptible and methicillin sodium-resistant Staphylococcus epidermidis vascular graft infection. 118
Effect of mono-dose intraperitoneal cecropins in experimental septic shock 116
Mupirocin as prophylactic agent against methicillin-susceptible, methicillin-resistant, and vancomycin-intermediate Staphylococcus epidermidis vascular graft infection. 114
Potential therapeutic role of histatin derivative P-113d in experimental rat models of Pseudomonas aeruginosa sepsis. 111
The lipopeptides Pal-Lys-Lys-NH(2) and Pal-Lys-Lys soaking alone and in combination with intraperitoneal vancomycin prevent vascular graft biofilm in a subcutaneous rat pouch model of staphylococcal infection 110
RNAIII-inhibiting peptide and/or nisin inhibit experimental vascular graft infection with methicillin-susceptible and methicillin-resistant Staphylococcus epidermidis. 110
Treatment of Staphylococcus aureus Biofilm infection by the quorum sensing inhibitor RIP 109
Efficacy of Tachyplesin III, Colistin and Imipenem against Multiresistant Pseudomonas aeruginosa 107
Efficacy of rifampin-levofloxacin as a prophylactic agent in preventing Staphylococcus epidermidis graft infection. 105
Therapeutic efficacy of the polymyxin-like peptide ranalexin in an experimental model of endotoxemia. 105
Efficacy of polycationic peptides in preventing vascular graft infection due to Staphylococcus epidermidis. 104
Pretreatment with the protegrin IB-367 affects Gram-positive biofilm and enhances the therapeutic efficacy of linezolid in animal models of central venous catheter infection. 104
Polycationic peptides as prophylactic agents against methicillin-susceptible and methicillin-resistant Staphylococcus epidermidis vascular graft infection 103
Glyoxalase II and glutathione levels in rat liver mitochondria during cold storage in Euro-Collins and University of Wisconsin solutions 102
RNAIII-inhibiting peptide improves efficacy of clinically used antibiotics in a murine model of staphylococcal sepsis. 102
The bovine antimicrobial peptide BMAP-28 reduces lethality due to bacterial cell wall components in mouse models of staphylococcal sepsis 101
Polycationic peptides as prophylactic agents against methicillin-susceptible or methicillin-resistant Staphylococcus epidermidis vascular graft infection. 100
Valore prognostico dell'indice Apache II nell'impiego routinario preoperatorio in chirurgia generale maggiore 99
Potential therapeutic role of cationic peptides in three experimental models of septic shock 98
Quinupristin/dalfopristin bonding in combination with intraperitoneal antibiotics prevent infection of knitted polyester graft material in a subcutaneous rat pouch model infected with resistant Staphylococcus epidermidis. 98
Single-dose intraperitoneal magainins improve survival in a gram-negative pathogens septic shock rat model. 96
Therapeutic efficacy of the magainin analog MSI-78 in different intra-abdominal sepsis rat models 95
Temporin A alone and in combination with imipenem reduces lethality in mouse models of staphylococcal sepsis 94
Potential therapeutic role of histatins derivative P-113D in experimental rat models of Pseudomonas sepsis 93
Temporin A Soaking in Combination with Intraperitoneal Linezolid Prevents Vascular Graft Infection in a Subcutaneous Rat Pouch Model Infected with Staphylococcus epidermidis with Intermediate Resistance to Glycopeptides 93
RNAIII inhibiting peptide significantly reduces bacterial load and enhances the effect of antibiotics in the treatment of central venous catheter-associated S. aureus infections 92
A novel Zip2 Gln/Arg/Leu codon 2 polymorphism is associated with carotid artery disease in aging 91
Prophylactic efficacy of linezolid alone or combined with levofloxacin and vancomycin in a rat subcutaneous pouch model of graft infection due to Staphylococcus epidermidis with intermediate resistance to glycopeptides 91
Temporin A as prophylactic agent against methicillin-susceptible and methicillin-resistant Staphylococcus epidermidis vascular graft infection. 91
The cathelicidin-derived tritrpticin enhances the efficacy of ertapenem in experimental rat models of septic shock 91
Efficacy of colistin/rifampin combination in experimental rat models of sepsis due to multiresistant Pseudomonas aeruginosa strain 90
RNAIII-inhibiting peptide improves efficacy of clinically used antibiotics in a murine models of staphylococcal sepsis 89
Interaction of antimicrobial peptide temporin L with lipopolisaccharide in vitro and in experimental rat models of Gram-negative septic shock. 87
RNA III Inhibiting Peptide (RIP) inhibits in vivo biofilm formation by drug-resistant Staphylococcus aureus 87
CD14 C (-260)T polymorphism, atherosclerosis, elderly: Role of cytokines and metallothioneins 74
Novel -209A/G MT2A polymorphism in old patients with type 2 diabetes and atherosclerosis: Relationship with inflammation (IL-6) and zinc 74
The +838 C/G MT2A polymorphism, metals, and the inflammatory/immune response in carotid artery stenosis in elderly people 55
Totale 11.133
Categoria #
all - tutte 45.468
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.468


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022410 0 0 0 27 3 54 15 30 35 92 24 130
2022/20231.040 106 114 91 81 91 106 0 50 286 7 84 24
2023/2024518 109 12 22 88 89 122 5 5 3 4 13 46
2024/20251.462 171 100 93 82 63 95 163 69 260 55 140 171
2025/20264.445 210 371 329 425 371 268 596 404 1.010 289 44 128
2026/2027810 138 140 210 322 0 0 0 0 0 0 0 0
Totale 11.133